[go: up one dir, main page]

BR9711671A - Tratamento com ácido graxo. - Google Patents

Tratamento com ácido graxo.

Info

Publication number
BR9711671A
BR9711671A BR9711671-8A BR9711671A BR9711671A BR 9711671 A BR9711671 A BR 9711671A BR 9711671 A BR9711671 A BR 9711671A BR 9711671 A BR9711671 A BR 9711671A
Authority
BR
Brazil
Prior art keywords
fatty acid
acid treatment
treatment
asset
cis
Prior art date
Application number
BR9711671-8A
Other languages
English (en)
Inventor
Catherine Ann Scott
David Frederick Horrobin
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of BR9711671A publication Critical patent/BR9711671A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

''TRATAMENTO COM áCIDO GRAXO''. O uso em preparação de um medicamento para tratamento e prevenção de efeitos colaterais de quimioterapia anti-câncer de um ácido graxo poli insaturado com um comprimento de cadeia carbono de 14 a 26 e com 2 a 6 ligações duplas na moléculas em configuração cis ou trans, e um processo de tal tratamento ou prevenção onde o dito ácido graxo é usado como um ativo.
BR9711671-8A 1996-09-04 1997-09-02 Tratamento com ácido graxo. BR9711671A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618420.5A GB9618420D0 (en) 1996-09-04 1996-09-04 Fatty acid treatment
PCT/GB1997/002362 WO1998009621A1 (en) 1996-09-04 1997-09-02 Fatty acid treatment

Publications (1)

Publication Number Publication Date
BR9711671A true BR9711671A (pt) 2000-01-18

Family

ID=10799374

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711671-8A BR9711671A (pt) 1996-09-04 1997-09-02 Tratamento com ácido graxo.

Country Status (10)

Country Link
US (2) US6407075B1 (pt)
EP (1) EP0956012A1 (pt)
JP (1) JP2000517339A (pt)
CN (1) CN1235542A (pt)
AU (1) AU4124997A (pt)
BR (1) BR9711671A (pt)
CA (1) CA2265526A1 (pt)
GB (1) GB9618420D0 (pt)
WO (1) WO1998009621A1 (pt)
ZA (1) ZA977902B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
GB9618420D0 (en) * 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment
AUPO851597A0 (en) * 1997-08-11 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Treatment of prostate cancer
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
WO2001017524A1 (en) * 1999-09-09 2001-03-15 Efa Sciences Llc. Methods for treating cell proliferative disorders including cancer
US6380253B1 (en) * 2000-01-05 2002-04-30 Efa Sciences Llc Method of stabilizing and potentiating the action of anti-angiogenic substances
EP1427407A4 (en) * 2001-03-23 2005-05-11 Luitpold Pharm Inc FAT AMIN DRUG CONJUGATES
EP1423107B1 (en) * 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
CA2448241A1 (en) 2001-05-31 2002-12-05 Wisconsin Alumni Research Foundation Conjugated nonadecadienoic acid compositions
JP3977162B2 (ja) * 2002-06-21 2007-09-19 株式会社バンダイナムコゲームス キャラクタ情報管理装置、プログラム及び情報記憶媒体
KR100585230B1 (ko) * 2003-12-27 2006-05-30 한국전자통신연구원 유무선 통합 인터넷 프로토콜망에서 패킷 유실과 전송지연을 감소시키는 티씨피 프록시 설정 방법 및 시스템
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
EP1996939B1 (en) * 2006-02-27 2014-03-26 Targeted Molecular Diagnostics, LLC Methods for predicting cardiac toxicity before and upon treatment with tyrosine kinase inhibitors
US10449224B2 (en) * 2007-05-25 2019-10-22 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using and compositions thereof
US10045951B2 (en) * 2007-05-25 2018-08-14 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex and its use thereof
US8324277B2 (en) 2007-08-01 2012-12-04 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
ES2692291T3 (es) 2008-05-01 2018-12-03 Complexa Inc. Ácidos grasos vinil sustituidos
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
EP2299997A4 (en) * 2008-06-19 2012-01-11 Univ Utah Res Found USE OF NITRATED LIPIDS FOR THE TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES
JP2013500966A (ja) * 2009-07-31 2013-01-10 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 抗炎症剤としての脂肪酸
EP2483233A4 (en) 2009-10-02 2013-08-14 Complexa Inc HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
EP2425833A1 (de) * 2010-09-03 2012-03-07 Fresenius Kabi Deutschland GmbH Die intravenöse Applikation von Fischöl/DHA +EPA vor bzw. mit Beginn der Chemotherapie
EP2744491B1 (en) 2011-08-19 2020-07-29 The University of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
EP2767277B1 (en) * 2011-10-12 2018-11-28 SBI Pharmaceuticals Co., Ltd. Treatment agent and/or prophylactic agent for side effects of cancer drugs
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
RU2554776C1 (ru) * 2013-12-16 2015-06-27 Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" СО РАМН Средство для коррекции нарушений в легочной ткани при цитостатическом воздействии
ES2971969T3 (es) 2015-07-07 2024-06-10 H Lundbeck As Inhibidores de PDE9 con cadena principal de imidazopirazinona para el tratamiento de enfermedades periféricas
KR20180098222A (ko) 2015-10-02 2018-09-03 컴플렉사, 인코포레이티드 활성화된 지방산의 치료학적 유효량을 이용한 질환의 예방, 치료 및 역행
TWI604744B (zh) * 2016-11-02 2017-11-01 財團法人工業技術研究院 無線網狀網路路由方法與無線節點
MX2019013683A (es) * 2017-05-16 2020-01-15 Ability Pharmaceuticals Sl Una combinacion farmaceutica para el tratamiento de un cancer.
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
MA52792A (fr) 2018-05-25 2021-04-14 Imara Inc Formes cristallines et monohydrate de 6- [(3s,4s)-4-méthyl-1-(pyrimidin-2-ylméthyl) pyrrolidin-3-yl]-3-tétrahydropyran-4-yl-7h-imidazo [1,5-a] pyrazin-8-one
KR20250108770A (ko) 2018-08-31 2025-07-15 카듀리온 파마슈티칼스, 인크. 겸상 세포 질환의 치료를 위한 pde9 억제제
JP7655598B1 (ja) 2024-03-29 2025-04-02 株式会社アイビー化粧品 ＴＧＦ－βシグナル伝達阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
GB8620917D0 (en) 1986-08-29 1986-10-08 Davidson B C Platinum derivatives & cancer treatments
JPS63258816A (ja) 1987-04-16 1988-10-26 Nippon Oil & Fats Co Ltd 抗癌剤組成物
GB9618420D0 (en) * 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment

Also Published As

Publication number Publication date
ZA977902B (en) 1998-08-11
US6407075B1 (en) 2002-06-18
GB9618420D0 (en) 1996-10-16
US20030017974A1 (en) 2003-01-23
JP2000517339A (ja) 2000-12-26
CN1235542A (zh) 1999-11-17
EP0956012A1 (en) 1999-11-17
CA2265526A1 (en) 1998-03-12
AU4124997A (en) 1998-03-26
WO1998009621A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
BR9711671A (pt) Tratamento com ácido graxo.
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
BR9909277A (pt) Compostos com atividade em receptores muscarìnicos
GB9807639D0 (en) Anti-inflammatory agents
DE69829112D1 (de) Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
DK0880350T3 (da) Behandling af dissemineret sklerose
BR9708553A (pt) Processo para limpeza de um substrato e uso de umsistema ativador de oxigenio molecular
BR9910834A (pt) Processo para a produção de um composto de ferro-dextrano
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
IT1295357B1 (it) Formulazioni cosmetiche utili nel trattamento preventivo e curativo della caduta dei capelli e loro uso
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
PT1035859E (pt) Utilizacao de complexos de fosfolipidos de extractos de vitis vinifera como agentes anti-ateroescleroticos
ATE293986T1 (de) Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
BRPI0415187A (pt) composição, método para matar bactérias, e, usos de composição e de bacteriófago
ES2001429A6 (es) Metodo para el tratamiento de masas de agua
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
EA199800819A1 (ru) Способ лечения биполярного расстройства
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
ITGE910107A1 (it) Unguento composto polivalente a base di sostanze naturali.
UA8280A (uk) Спосіб лікування псоріазу
UA15819C2 (uk) Лікувальhо-косметичhий засіб "пелос"

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired